Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.07.24.740589

Evaluation of harmonization methods to mitigate assay and cohort effects in plasma p-tau217

Abstract

INTRODUCTIONThe growing number of assay platforms measuring blood-based biomarkers (BBMs) for Alzheimers disease (AD) has introduced challenges in interpretability and comparability across assays. Differences across studies also limit comparability of data. To address these challenges, a systematic evaluation of harmonization methods is needed to support BBM data integration within or across studies. METHODSTwo multisite studies, Alzheimers Disease Neuroimaging Initiative (ADNI, n = 219) and Human Connectome Project (HCP, n = 111), were used to evaluate harmonization methods for mitigating assay and cohort effects in plasma p-tau217 measurements. Methods includes various normalization, regression, and standardization approaches, including the recently developed CentiMarker. Assay effects were evaluated using repeated-measures data across assay platforms within each cohort, whereas cohort effects were assessed using pooled ADNI and HCP data. Harmonization performance was evaluated using distributional statistics and downstream modeling of p-tau217. RESULTSQuantile normalization and quantile mapping methods were most effective for mitigating assay effects, whereas conditional quantile mapping performed best for pooled multi-cohort data. These methods also preserved biological variability. In contrast, simple means adjustment and reference-based z-score standardization were least effective for mitigating assay effects, while simple means adjustment, z-score standardization, and quantile normalization were least effective for mitigating cohort effects. CentiMarker had minimal impact on assay or cohort effects. DISCUSSIONBased on our evaluation, we recommend (conditional) quantile mapping for p-tau217 studies integrating data across multiple assays or cohorts. In contrast, we caution against using CentiMarker and z-score-based methods, as they limit comparability and do not effectively mitigate technical variability.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zhang, V. Z., Ferreira, P. C. L., Dong, Y., Minhas, D., Povala, G., Bellaver, B., Pascoal, T. A., Zeng, X., Karikari, T. K., Cohen, A. D., Deek, R. A., Wu, Q., Tudorascu, D. L.. 2026-07-28. Evaluation of harmonization methods to mitigate assay and cohort effects in plasma p-tau217. https://doi.org/10.64898/2026.07.24.740589

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Bullying Victimisation, Medial Occipital White Matter Development, and Psychotic-Like Experiences: A Longitudinal Diffusion MRI Study

Childhood bullying victimisation is robustly associated with psychotic-like experiences, but the neurodevelopmental mechanisms underlying this association remain unclear. This longitudinal study examined whether childhood bullying victimisation was associated with altered maturation of medial occipital white matter and whether bullying victimisation moderated the association between fractional anisotropy (FA) and psychotic-like experiences. A total of 96 young people (38 bullied, 58 controls) from the Adolescent Brain Development study underwent diffusion MRI at approximately 14, 16, and 20 years of age. PLE and bullying victimisation group classification were determined by expert consensus interview. FA from bilateral calcarine-cuneus, cuneus-lingual, and calcarine-lingual connections was examined using mixed-effects models. Compared with controls, the bullied group showed significantly different age-related FA trajectories in the right calcarine-cuneus connection ({beta} = -0.40, p < .001) and the left cuneus-lingual connection ({beta} = -0.35, p = .003). Bullying victimisation significantly moderated the association between white matter FA and PLE ({beta} = -6.14, p = .004), indicating that the association between FA and psychotic-like experiences differed according to bullying victimisation status. This moderation effect also varied with age, as indicated by a significant bullying victimisation-by-FA-by-time interaction ({beta} = -6.80, p = .008). Specifically, the moderating effect of bullying victimisation on the association between right calcarine-cuneus FA and PLE changed across development. These findings suggest that bullying victimisation is associated with divergent maturation of medial occipital circuitry and identify right calcarine-cuneus development as a potential marker of vulnerability to PLE following childhood bullying.

neuroscience↗

The social conditioned place preference assay is sensitive to drug dose, training regimen, and social context

Beginning in the 1960s, researchers have understood that one of the unique properties of psychedelic drugs is that their effects are modified by the context in which they are taken (also known as their set and setting dependence). To date, 7 different studies have shown that critical period reopening is a shared property across psychedelic drugs, including ketamine, MDMA, psilocybin, LSD, and ibogaine. Moreover, the context dependence of psychedelics effects has been recapitulated for both MDMA and ketamine. Recently, Lu et al., Nature Neuroscience 2026 (PMID: 42972049) have claimed that psilocybin does not reopen the social reward learning critical period, which the authors interpret as a failure to replicate previously published results. Here, we re-analyzed results across three published datasets (Nardou et al., Nature 2019; Nardou et al., Nature 2023; Lu et al., Nature Neuroscience 2026) in order to compare the impact of dose, training regimen, and social context on the social conditioned place preference (social CPP) assay. Our analysis reveals that methodological modifications likely account for Lu and colleagues inability to reopen the social reward learning critical period with psilocybin. Nevertheless, because their results recapitulate previous findings that psychedelics effects are context dependent, they support rather than challenge the growing literature demonstrating that psychedelics reopen critical periods.

neuroscience↗

Harmonizing amyloid PET tracers at the local level: evaluation of regional Centiloid equations

INTRODUCTION: The Centiloid (CL) framework standardizes global amyloid-PET across radiotracers. While global scaling remains essential for participant selection, amyloid-targeting therapies require quantifying localized plaque removal. However, applying global equations regionally introduces systematic bias, particularly in subcortical structures where off-target binding alters non-specific background. METHODS: We extended the Centiloid framework regionally and voxel-wise using GAAIN datasets: Level-1 ([11C]PiB) and Level-2 paired [11C]PiB and fluorinated head-to-head cohorts ([18F]florbetaben, [18F]florbetapir, [18F]flutemetamol, and [18F]NAV4694). Level-1 defines the regional Centiloid scale using region-specific intercepts while fixing the global slope. Level-2 calibrates fluorinated tracer uptake to reference [11C]PiB SUVR using linear equations. We compared three slope-intercept models (Global, Regional-Intercept, and Regional) using information criteria and Mean Absolute Error (MAE). RESULTS: Regional-Intercept model was identified as optimal across all four radiotracers. In neocortical regions, Global and Regional-Intercept models showed high agreement across canonical lobes. In deep gray matter, global equations introduced large systematic offsets, with mean absolute conversion errors in the pallidum reaching 27.7 to 45.6 CL. The Regional-Intercept model eliminated this bias, reducing subcortical MAE on average below 15 CL while preserving a unified biological scale. DISCUSSION: Applying global Centiloid equations directly to regions introduces substantial bias in subcortical regions. With the Regional-Intercept model, the same Centiloid value corresponds to the same amyloid concentration across brain regions and radiotracers. This provides a reliable basis for cross- sectional regional evaluation, multi-tracer cohort pooling, tracking regional clearance, and mapping regional progression in clinical research.

neuroscience↗